School, Sleep and Caregiver Burden in Childhood Eczema: The PEDI-BURDEN Survey
Evidence review: This article examines one specific study and keeps its results separate from cosmetic product claims. The featured scene is an AI-created illustration of fictional people and is not a patient photograph, diagnosis, before-and-after image, or treatment result.
The practical question
How can childhood eczema affect a family even on days when the child is physically present at school?
The survey looked beyond absence. Parents reported restless nights for children and caregivers, daytime drowsiness, bullying, concentration difficulty and family strain. Presenteeism—being present but unable to focus—accounted for more of the estimated study impairment than absence. These are burden signals that can help schools ask better questions, not a scorecard for an individual child.
Study snapshot
| Study element | What was reported |
|---|---|
| Population | 160 Italian children age 6–11 meeting reported AD criteria and POEM ≥8, compared with 100 age-matched controls |
| Design | Parent-reported online cross-sectional survey |
| Timepoint | Questions covered the prior 12 months; data collected September–December 2021 |
| Key result | Bullying at school was reported for 20% versus 9%; estimated annual study impairment was 37.8 days (17.7 absenteeism plus 20.1 presenteeism) |
How to read the numbers
The most useful number is the one tied to the study’s actual design and denominator. Here, the central finding was: Bullying at school was reported for 20% versus 9%; estimated annual study impairment was 37.8 days (17.7 absenteeism plus 20.1 presenteeism). That finding applies to 160 italian children age 6–11 meeting reported ad criteria and poem ≥8, compared with 100 age-matched controls. It should not be stretched to different ages, occupations, climates or disease severities without new evidence.
A statistically significant result can still be limited in size, duration or generalizability. Conversely, a null clinical score does not mean that every practical outcome was unchanged. This review therefore separates measured clinical severity, reported behavior, function and quality of life instead of treating them as interchangeable.
What the study does not establish
Diagnosis, severity and outcomes were parent-reported online. The 160 included children came from 3,067 invitations and met POEM and location criteria, so selection and recall bias are possible. Adding reported absence and presenteeism produces an estimate, not verified attendance records. Cross-sectional comparisons cannot prove eczema caused every psychosocial outcome.
The paper is indexed or archived by the U.S. National Library of Medicine, but that hosting does not mean NIH endorses the study’s interpretation or any product. Read the primary record at PMCID PMC10106808. For a broader clinical overview, see NIAMS information on atopic dermatitis and the American Academy of Dermatology’s skin-care guidance.
Applying the evidence to school participation and family routines
Caregivers can coordinate a written school plan covering prescribed treatments, permitted skincare, heat and activity adjustments, sleep-related fatigue, bullying response and when to call home. Children should not be singled out or asked to manage medical decisions alone. Product use in children should be discussed with the child’s healthcare professional.
Helpful routines are usually specific: identify the exposure, decide what change is feasible, measure whether symptoms or participation improve, and revisit the plan. Seek professional care for persistent, infected, painful, widespread or function-limiting dermatitis, or when the diagnosis is uncertain.
Where a cosmetic moisturizer fits
Dr. Arsy #003 is a cosmetic moisturizer intended to support hydration, the moisture barrier and dry-skin comfort. It is not an eczema medicine and this external study did not test it. Adults choosing a fragrance-free daily moisturizer can review the Dr. Arsy #003 4 oz / 120 g product page; children and people with active or diagnosed skin disease should follow appropriate professional guidance.
Continue the evidence series
New in this Life in Motion series
- Sweat Management and Adult Eczema: What a 34-Person Pilot Actually Found
- Sweating Response in Atopic Dermatitis: A 26-Patient Thermal-Stress Study
Bottom line
This study contributes a focused piece of evidence about school participation and family routines. Its value comes from preserving the population, comparator, timepoint and limitations—not from converting an association or workplace program into a universal promise. Use the findings to ask more precise questions and build a realistic plan with the right clinician or occupational-health professional.